Uncategorized
Collaboration boosts AAV vectors for gene therapy
Avalanche Biotechnologies Inc. and Lonza have announced a manufacturing collaboration focused on
process development and scale-up efforts for the manufacturing of adeno-associated viral (AAV) vectors for gene
therapy.